The table below shows AMICUS THERAPEUTICS, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Q1 2020
Operating cash flow
$7.76M
-$29.70M
-$18.07M
-$58.31M
-$72.35M
-$107.94M
Capital expenditure
$212.00K
$1.81M
$1.94M
$871.00K
$868.00K
$806.00K
Investing cash flow
-$32.86M
$7.54M
$36.26M
$58.21M
$86.56M
$93.25M
Dividends paid
-
-
-
-
FOLD operating cash flow (10-K history)
AMICUS THERAPEUTICS, INC. reported operating cash flow of $33.15M for fiscal year 2025. That is up 197.8% from -$33.89M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$150.15M (FY 2016) to $33.15M. Figures come from the company's audited annual reports as filed with the SEC.
